IN THE NEWS

THE LATEST NEWS

Harvard Business Review: Using AI to Understand What Causes Diseases

Cigna Invests In GNS Healthcare Precision Medicine Venture

GNS Among Ways Amgen is Applying AI to Combat Serious Illness

Iya Khalil weighs in on AI in Real-World Drug Discovery

GNS CEO Colin Hill joins rank of Top 50 Healthcare Technology CEOs of 2019

Adding Artificial Intelligence to Drug Discovery – Iya Khalil interviewed by GEN News

GNS Co-founder, Iya Khalil interviewed by BioCentury: A Frequentist and a Bayesian Walk Into a Trial

How A.I. Is Finding New Cures in Old Drugs

GNS Co-Founder Iya Khalil Named to Forbes list of “50 Women-Led Startups That Are Crushing Tech”

GNS Co-Founder and CEO Colin Hill Discusses how AI will Power the Future of in silico Clinical Trials